Thymic size on chest radiograph and rapid disease progression in human immunodeficiency virus 1-infected children

被引:23
|
作者
Meyers, A [1 ]
Shah, A
Cleveland, RH
Cranley, WR
Wood, B
Sunkle, S
Husak, S
Cooper, ER
机构
[1] Boston Med Ctr, Div Gen Pediat, Boston, MA 02118 USA
[2] Boston Med Ctr, Div Pediat Infect Dis, Boston, MA 02118 USA
[3] Boston Med Ctr, Dept Radiol, Boston, MA 02118 USA
[4] Childrens Hosp, Dept Radiol, Boston, MA 02115 USA
[5] Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA
[6] Univ So Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA USA
关键词
human immunodeficiency virus; acquired immunodeficiency syndrome; thymus; children; vertical transmission;
D O I
10.1097/00006454-200112000-00004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Early infection of the thymus, an organ central to the ontogeny of the immune system, has been proposed as a cause of rapid progression in pediatric HIV disease. Objective. To test the hypothesis that small thymic volume is associated with rapid disease progression in HIV-infected children. Design. Three pediatric radiologists established criteria for rating the size of the thymic profile on chest radiographs. All available baseline chest radiographs were reviewed in a random sequence, with radiologists blinded to study subjects' clinical status. A consensus was reached on whether the thymus was normal or small for age. Setting. A prospective multicenter study of the natural history of HIV-1 infection in children, the Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted Human Immunodeficiency Virus Infection ((PC2)-C-2) Study. Patients. Fifty-eight HIV-infected children and 38 control children (uninfected but born to HIV-infected women) for whom chest radiographs in the first year of life were available. Main outcome measure. Rapid progression of HIV disease, defined as CDC Clinical Category C (severely symptomatic) or Immunologic Category 3 (severe immunosuppression) by 1 year of age. Results. The mean age at the time of chest radiography was 3.5 months. Ten (17%) HIV-infected children had reduced thymic profile size, whereas no controls did (P = 0.006). Of the 58 (59%) HIV-infected children 34 were classified as rapid progressors, and 9 (26%) of them had reduced thymus size, compared with 1 (4%) of the non-rapid progressor children [odds ratio, 8.28; 95% confidence interval (CI), 1.0, 70.5; P = 0.035]. Baseline mean CD4(+) count was 1642 (95% CI 1322 to 2009) cells/mul for those with normal thymus and 740 (95% CI 380 to 1275) cells/mul for those with reduced thymus (P = 0.007). Conclusion. Early thymic involution is associated with rapidly progressive disease in HIV-infected children.
引用
收藏
页码:1112 / 1118
页数:7
相关论文
共 50 条
  • [1] Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India
    Mehendale, SM
    Bollinger, RC
    Kulkarni, SS
    Stallings, RY
    Brookmeyer, RS
    Kulkarni, SV
    Divekar, AD
    Gangakhedkar, RR
    Joshi, SN
    Risbud, AR
    Thakar, MA
    Mahajan, BA
    Kale, VA
    Ghate, MV
    Gadkari, DA
    Quinn, TC
    Paranjape, RS
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (16) : 1175 - 1179
  • [2] Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children
    Balotta, C
    Colombo, MC
    Colucci, G
    Vigano, A
    Riva, C
    Papagno, L
    Violin, M
    Crupi, L
    Bricalli, D
    Salvaggio, A
    Moroni, M
    Principi, N
    Galli, M
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (02) : 205 - 211
  • [3] Cytomegalovirus infection in human immunodeficiency virus type 1-infected children
    Chandwani, S
    Kaul, A
    Bebenroth, D
    Kim, M
    DiJohn, D
    Fidelia, A
    Hassel, A
    Borkowsky, W
    Krasinski, K
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (04) : 310 - 314
  • [4] Rapid disease progression in human immunodeficiency virus type 1-Infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis
    Veenstra, J
    Veugelers, PJ
    Keet, IPM
    vanderVen, AJAM
    Miedema, F
    Lange, JMA
    Coutinho, RA
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (05) : 936 - 941
  • [5] Rubella immunization in human immunodeficiency virus type 1-infected children
    Lima, M
    Succi, RCD
    Dos Santos, AMN
    Weckx, LY
    de Moraes-Pinto, MI
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (07) : 604 - 607
  • [6] Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants
    Rich, KC
    Fowler, MG
    Mofenson, LM
    Abboud, R
    Pitt, J
    Diaz, C
    Hanson, IC
    Cooper, E
    Mendez, H
    [J]. PEDIATRICS, 2000, 105 (01) : e8
  • [7] Activation of the CD95 system increases with disease progression in human immunodeficiency virus type 1-infected children and adolescents
    Bohler, T
    Baumler, C
    Herr, I
    Groll, A
    Kurz, M
    Debatin, KM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (08) : 754 - 759
  • [8] Measles antibody in vaccinated human immunodeficiency virus type 1-infected children
    Arpadi, SM
    Markowitz, LE
    Baughman, AL
    Shah, K
    Adam, H
    Wiznia, A
    Lambert, G
    Dobroszycki, J
    Heath, JL
    Bellini, WJ
    [J]. PEDIATRICS, 1996, 97 (05) : 653 - 657
  • [9] Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children
    Ometto, L
    Bertorelle, R
    Mainardi, M
    Zanchetta, M
    Tognazzo, S
    Rampon, O
    Ruga, E
    Chieco-Bianchi, L
    de Rossi, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (05): : 814 - 818
  • [10] IMMUNOLOGICAL CHARACTERIZATION OF CHILDREN VERTICALLY INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, WITH SLOW OR RAPID DISEASE PROGRESSION
    VIGANO, A
    PRINCIPI, N
    VILLA, ML
    RIVA, C
    CRUPI, L
    TRABATTONI, D
    SHEARER, GM
    CLERICI, M
    [J]. JOURNAL OF PEDIATRICS, 1995, 126 (03): : 368 - 374